- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
7
Companies which are more than 50% undervalued based on analyst price target.
7 companies
Caliway Biopharmaceuticals
Market Cap: NT$165.8b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$106.50
7D
-0.9%
1Y
-20.2%
Bora Pharmaceuticals
Market Cap: NT$50.0b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$392.50
7D
-7.0%
1Y
-43.5%
Lotus Pharmaceutical
Market Cap: NT$49.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$189.00
7D
-3.8%
1Y
-15.2%
Oneness Biotech
Market Cap: NT$22.9b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$47.80
7D
-6.3%
1Y
-27.2%
TaiMed Biologics
Market Cap: NT$16.1b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$58.90
7D
-8.4%
1Y
-31.9%
Medigen Vaccine Biologics
Market Cap: NT$15.5b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$47.00
7D
2.5%
1Y
11.4%
Foresee Pharmaceuticals
Market Cap: NT$12.6b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.70
7D
-2.8%
1Y
8.0%